Fischer Medical Ventures Ltd — Board Meeting, 28-05-2025: Board Meeting

Fischer Medical Ventures Limited has announced a board meeting outcome approving the financial results for the quarter and half-year ended March 31, 2025. The company reported standalone revenue of ₹521.97 lakhs for the quarter and ₹1,152.83 lakhs for the year, with a standalone net loss of ₹89.05 lakhs for the quarter but a profit of ₹66.32 lakhs for the year. Consolidated revenue rose to ₹4,917.42 lakhs for the quarter and ₹11,069.87 lakhs for the year, delivering a consolidated net profit of ₹131.22 lakhs for the quarter and ₹120.79 lakhs for the year. The board has recommended a final dividend of Rs. 0.05 per share, subject to shareholder approval. They approved the re-appointment of M/s. Bilimoria Mehta & Co. as statutory auditors for five years and appointed S. Ramanand Aiyer & Co. as internal auditors for FY 2025-26. The company also plans listing on the NSE main board. The audited reports carry unmodified opinions. Recent incorporations of subsidiaries have been consolidated, supporting group expansion.